<DOC>
	<DOCNO>NCT00752596</DOCNO>
	<brief_summary>This open-label , long term compassionate use study 125 mg per day azimilide 2HCl patient complete two protocol ( 2000098 2001060 .</brief_summary>
	<brief_title>Compassionate Use Study 125 mg Per Day Azimilide Dihydrochloride One Patient</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Azimilide</mesh_term>
	<criteria>No inclusion criterion patient include compassionate use protocol currently receive azimilide therapy Currently take Class I Class III antiarrhythmic drug drug may prolong QT interval . Is unwilling unable give understand inform consent .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>patient</keyword>
	<keyword>ICD</keyword>
</DOC>